PT  - JOURNAL ARTICLE
AU  - Sally Barrington
AU  - Philip Blower
AU  - Gary Cook
TI  - New horizons in multimodality molecular imaging and novel radiotracers
AID  - 10.7861/clinmedicine.17-5-444
DP  - 2017 Oct 01
TA  - Clinical Medicine
PG  - 444--448
VI  - 17
IP  - 5
4099  - http://www.rcpjournals.org/content/17/5/444.short
4100  - http://www.rcpjournals.org/content/17/5/444.full
SO  - Clin Med2017 Oct 01; 17
AB  - Positron emission tomography (PET)/computerised tomography is now established in clinical practice for oncologic and non-oncological applications. Improvement and development of scanner hardware has allowed faster acquisitions and wider application. PET/magnetic resonance imaging offers potential improvements in diagnostic accuracy and patient acceptability but clinical applications are still being developed. A range of new radiotracers and non-radioactive contrast agents is likely to lead to a growth in hybrid molecular imaging applications that will allow better characterisation of disease processes.